Literature DB >> 18534730

Spurious hyperphosphatemia in patients on hemodialysis with catheters.

Brigitte Schiller1, Bhupinder Virk, Martin Blair, Amy Wong, John Moran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18534730      PMCID： PMC4088958          DOI： 10.1053/j.ajkd.2008.03.033

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  8 in total

1.  Spurious hyperphosphatemia due to sample contamination with heparinized saline from an indwelling catheter.

Authors:  Cindy L Ball; Kathleen Tobler; B Catherine Ross; M Ruth Connors; Martha E Lyon
Journal:  Clin Chem Lab Med       Date:  2004-01       Impact factor: 3.694

2.  Spurious hyperphosphatemia in a patient with alteplase-locked central venous catheter.

Authors:  Francois Cachat; Daniel Bardy; Claudine Durussel; Ermindo Di Paolo
Journal:  Pediatr Nephrol       Date:  2005-12-03       Impact factor: 3.714

3.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study.

Authors:  G A Block; T E Hulbert-Shearon; N W Levin; F K Port
Journal:  Am J Kidney Dis       Date:  1998-04       Impact factor: 8.860

4.  Determinants of progressive vascular calcification in haemodialysis patients.

Authors:  Glenn M Chertow; Paolo Raggi; Scott Chasan-Taber; Juergen Bommer; Herwig Holzer; Steven K Burke
Journal:  Nephrol Dial Transplant       Date:  2004-04-21       Impact factor: 5.992

Review 5.  Pseudohyperphosphatemia.

Authors:  A J Larner
Journal:  Clin Biochem       Date:  1995-08       Impact factor: 3.281

6.  Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

Authors:  Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

7.  Hyperphosphatemia in multiple myeloma due to a phosphate-binding immunoglobulin.

Authors:  J M Mandry; M R Posner; J R Tucci; C Eil
Journal:  Cancer       Date:  1991-09-01       Impact factor: 6.860

8.  Pseudohyperphosphataemia incidence in an automatic analyzer.

Authors:  A M Cohen; A Magazanik; E van-der Lijn; P Shaked; H Levinsky
Journal:  Eur J Clin Chem Clin Biochem       Date:  1994-07
  8 in total
  2 in total

Review 1.  Hyperphosphataemia: treatment options.

Authors:  Fabio Malberti
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

2.  Pseudohyperphosphatemia due to contamination with heparin: A case for caution.

Authors:  S Senthilkumaran; R G Menezes; S Jayaraman; P Thirumalaikolundusubramanian
Journal:  Indian J Nephrol       Date:  2014-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.